NEWS
BASF buys into Chinese actives, Indian tropical red seaweed
BASF has made a strategic investment in Ingredi, a Chinese supplier of natural actives and solutions for the personal care industry. Ingredi, established in 2017,
develops active ingredients from natural plants found in the Himalayas area of China. Through the equity investment
from BASF, Ingredi will be able to extend its production facilities. In addition, BASF will jointly
work with Ingredi to identify new solutions and commercialise these to the global personal care market. “While the traditional Chinese medicine (TCM) market is known by many consumers, the use of plant-based actives with a TCM background is a new trend in the personal care industry and continues to grow fast,” said BASF in a statement.
“BASF contributes its expertise in demonstrating how to successfully add these ingredients into personal care formulations and will market these products globally to its customers,” it added. The value of BASF’s investment
in Ingredi was not disclosed. In a related development, BASF
has invested in Sea6 Energy, an Indian producer of tropical red seaweed used as an ingredient in cosmetics and other products. In conjunction with Aqua-Spark, a Dutch investment fund focusing
on the global aquaculture industry, and Tata Capital Innovations Fund, BASF Venture Capital has invested around $18.5m in the Bangalore outfit. In addition to cosmetics,
biomass from the fast-growing red seaweed is suitable as a raw material for animal feed and crop protection products, as a gelling ingredient in the food industry. The market volume for seaweed
products was almost $17 billion in 2020. However, commercial offshore cultivation on a large scale is complex, and the technical systems must withstand adverse weather conditions, such as storms and waves. Sea6 Energy has adapted
its cultivation technology to the conditions in deeper water and adverse weather conditions and covers both parts of the value chain
with its integrated business model. To identify the right locations with the right conditions for its farms, Sea6 Energy uses satellite imagery, for example. Under suitable conditions, at least six harvests per year are possible. Sea6 operates various plants
in Tuticorin, India, for the further processing of red seaweed for different applications. For example, the company produces biostimulants for use in agriculture and shrimp farming that increase resistance to disease and stress. In addition, Sea6 Energy has
developed a proprietary process that increases the shelf life of red seaweed from one to two days to up to 60 days. This facilitates the transport of fresh red seaweed, which can otherwise only be transported over longer distances once it has been dried.
Global Amines to acquire Clariant quats business
Global Amines, a 50-50 joint venture between Clariant and Wilmar, is to acquire the global quats and esterquats business from Clariant for $113 million. The acquisition is subject
to regulatory approvals and is expected to close in the first half of 2023.
With production assets located
in Germany, Brazil and Indonesia, the quats and esterquats business of Clariant includes products sold
under the Praepagen and Genamin trademarks in the home and personal care market. The business is a leading
supplier of quats with proprietary technology and the products are used in a broad range of products including hair conditioners. “The quats and esterquats business is an ideal fit for Global Amines as it perfectly complements our product portfolio and our ability to offer customers the best and
most competitive solutions from a complete range of amines, quats, amines derivatives and betaines,” said Ernesto Horikoshi, group general manager of Global Amines. “The acquisition plays to the
JV’s strategic strengths by building on Clariant’s long-standing experience in specialties chemicals and Wilmar’s position as Asia’s leading agribusiness and on its global oleochemicals business,” he added.
US firm Locus enters European surfactants market
US firm Locus Performance Ingredients’ full lines of Ferma and Amphi lactonic and linear sophorolipid biosurfactants have received REACH registrations from the European Chemicals Agency (ECHA). The registrations provide
EU formulators with access to multifunctional biosurfactant ingredients that enhance product sustainability and performance, the Ohio company said.
www.personalcaremagazine.com The European expansion
of Locus’ sophorolipids will be driven by industry expert, Ronald Lieffering. His CV includes R&D and
leadership roles at top specialty chemical companies. Based in the Netherlands, Lieffering will act as Locus’s vice president for Europe, the Middle East and Africa (EMEA). “The specialty chemical market
is rapidly evolving towards more sustainable offerings, and green chemistries like biosurfactants are
the future,” said Lieffering. “Locus Performance
Ingredients’ sophorolipids have unmatched multifunctionality and impressive mechanisms of action. They are a true game-changer for clean-label formulations across all CPG and industrial formulations throughout Europe, and the rest of the world.”
Locus PI’s sophorolipids
belong to the glycolipid class of biosurfactants and provide unique multifunctionality benefits to formulators. They are said to enhance
performance at minimal usage rates to keep formulation costs low and reduce formulation complexity. “The REACH registrations
encompass our full range of sophorolipids,” added Lieffering.
October 2022 PERSONAL CARE
9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108
